Norris Perne & French LLP Abbott Laboratories Transaction History

Norris Perne & French LLP

$1.36 Billion
Q3 2024

A detailed history of Norris Perne & French LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Norris Perne & French LLP holds 226,216 shares of ABT stock, worth $26.1 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

226,216

Previous 228,760 1.11%

Holding current value

$26.1 Million

Previous $23.8 Million 8.5%

% of portfolio

1.9%

Previous 1.83%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $254,578 - $300,522	-2,544 Reduced 1.11%	226,216 $25.8 Million
Q2 2024 Jul 24, 2024	BUY	$100.73 - $112.44 $8.5 Million - $9.49 Million	84,416 Added 58.48%	228,760 $23.8 Million
Q1 2024 Apr 16, 2024	BUY	$109.52 - $120.96 $192,864 - $213,010	1,761 Added 1.24%	144,344 $16.4 Million
Q4 2023 Jan 22, 2024	BUY	$90.19 - $110.4 $212,758 - $260,433	2,359 Added 1.68%	142,583 $15.7 Million
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $251,339 - $301,565	2,631 Added 1.91%	140,224 $13.6 Million
Q2 2023 Jul 19, 2023	BUY	$100.78 - $112.29 $160,038 - $178,316	1,588 Added 1.17%	137,593 $15 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $105,093 - $123,700	1,085 Added 0.8%	136,005 $13.8 Million
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $316,264 - $371,027	-3,327 Reduced 2.41%	134,920 $0
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $153,654 - $177,903	1,588 Added 1.16%	138,247 $13.4 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $210,978 - $255,005	2,067 Added 1.54%	136,659 $14.8 Million
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $159,285 - $194,238	1,397 Added 1.05%	134,592 $15.9 Million
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $173,063 - $211,907	1,498 Added 1.14%	133,195 $18.7 Million
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $346,713 - $383,566	2,972 Added 2.31%	131,697 $15.6 Million
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $373,544 - $439,715	3,531 Added 2.82%	128,725 $14.9 Million
Q1 2021 Apr 30, 2021	BUY	$108.84 - $128.23 $1.8 Million - $2.12 Million	16,494 Added 15.17%	125,194 $15 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $254,835 - $277,697	2,427 Added 2.28%	108,700 $11.9 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $89,440 - $108,619	-976 Reduced 0.91%	106,273 $11.6 Million
Q2 2020 Jul 23, 2020	BUY	$76.57 - $98.0 $106,355 - $136,122	1,389 Added 1.31%	107,249 $9.81 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $82,859 - $121,163	-1,319 Reduced 1.23%	105,860 $8.35 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $9.63 Million - $10.7 Million	-122,704 Reduced 53.38%	107,179 $9.31 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $81,103 - $87,941	-991 Reduced 0.43%	229,883 $19.2 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $13,191 - $15,385	-181 Reduced 0.08%	230,874 $19.4 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $3.46 Million - $4.18 Million	-52,197 Reduced 18.43%	231,055 $18.5 Million
Q4 2018 Jan 28, 2019	BUY	$65.56 - $74.27 $153,475 - $173,866	2,341 Added 0.83%	283,252 $20.5 Million
Q3 2018 Oct 29, 2018	BUY	$60.81 - $73.36 $5.97 Million - $7.2 Million	98,140 Added 53.7%	280,911 $20.6 Million
Q2 2018 Jul 24, 2018	BUY	$57.57 - $63.54 $329,012 - $363,131	5,715 Added 3.23%	182,771 $11.1 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $109,839 - $124,186	1,952 Added 1.11%	177,056 $10.6 Million
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $299,104 - $320,222	-5,572 Reduced 3.08%	175,104 $9.99 Million
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $8.68 Million - $9.69 Million	180,676	180,676 $9.64 Million

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Abbott Laboratories Transaction History